Competing hydrogen-bond and halogen-bond donors in crystal engineering by Aakeröy, Christer B. et al.
This is the author’s final, peer-reviewed manuscript as accepted for publication.  The 
publisher-formatted version may be available through the publisher’s web site or your 
institution’s library.  
This item was retrieved from the K-State Research Exchange (K-REx), the institutional 
repository of Kansas State University.  K-REx is available at http://krex.ksu.edu 
 
Competing hydrogen-bond and halogen-bond donors in 
crystal engineering 
 
Christer B. Aakeröy, Sheelu Panikkattu, Prashant D. Chopade, John Desper 
 
 
How to cite this manuscript 
 
If you make reference to this version of the manuscript, use the following information: 
 
Aakeröy, C. B., Panikkattu, S., Chopade, P. D., & Desper, J. (2013). Competing 
hydrogen-bond and halogen-bond donors in crystal engineering. Retrieved from 
http://krex.ksu.edu 
 
 
 
Published Version Information 
 
 
Citation: Aakeröy, C. B., Panikkattu, S., Chopade, P. D., & Desper, J. (2013). 
Competing hydrogen-bond and halogen-bond donors in crystal engineering. 
CrystEngComm, 15(16), 3125-3136. 
 
 
 
Copyright: © The Royal Society of Chemistry 2013 
 
 
 
Digital Object Identifier (DOI): doi:10.1039/c2ce26747k 
 
 
 
Publisher’s Link: http://pubs.rsc.org/en/Content/ArticleLanding/2013/CE/c2ce26747k 
 
 
 
Journal Name 
Cite this: DOI: 10.1039/c0xx00000x 
www.rsc.org/xxxxxx 
Dynamic Article Links ►
PAPER
 
This journal is © The Royal Society of Chemistry [year] [journal], [year], [vol], 00–00  |  1 
Competing hydrogen-bond and halogen-bond donors in crystal 
engineering 
Christer B. Aakeröy,*a Sheelu Panikkattu, a Prashant D. Chopade, a and John Desper a 
 
In order to study the structure-directing competition between hydrogen- and halogen-bond donors we 5 
have synthesized two ligands, 3,3’-azobipyridine and 4,4’-azobipyridine, and co-crystallized them with a 
series of bi-functional donor molecules comprising an activated halogen-bond donor (I or Br) as well as a 
hydrogen-bond donor (acid, phenol or oxime) on the same backbone. Based on the subsequent single- 
crystal analysis, 5 of 6 co-crystals of 3,3’-azobipyridine are assembled using hydrogen bonds as the 
primary driving force accompanied by weaker secondary (C-XO) interactions. However, in 5 out of the 10 
6 co-crystals of 4,4’-azobipyridine, both hydrogen bonds (O-HN) and halogen bonds (C-XN) are 
present as comparable structure-directing interactions leading to 1-D chains. Since the charges on the 
acceptor sites in 3,3’-and 4,4’-azobipyridine are very similar, i.e. -174 and -172 kJ/mol respectively, the 
observed difference in binding behaviour highlights the importance of binding-site location on the 
acceptor molecules (anti-parallel in 3,3’-azobipyridine and co-linear in 4,4’-azobipyridine) as a direct 15 
influence over the structural  balance between hydrogen- and halogen-bond donors. 
Introduction 
Many hydrogen-bond based synthons1 such as acidpyridine2, 
acidamide3, phenolpyridine4, oximeN(heterocycle)5 have 
been explored extensively as robust and reliable tools for 20 
crystal engineering and supramolecular synthesis. Recently, 
halogen bonds6 which can play important roles in areas such 
as biochemistry7, medicinal chemistry8, and material science,9  
have found uses in crystal engineering because these 
interactions have properties that parallel those of hydrogen 25 
bonds in terms of directionality and strength.10,11 Typical 
hydrogen-bond strength ranges from approximately 4-60 
kJ/mol12 while halogen bonds range from 5-180 kJ/mol (the 
strong interaction I2I- in I3- is the extreme).13 Consequently, 
iodine/bromine suitably ‘activated’ through a fluorinated 30 
backbone should be capable of competing with hydrogen 
bonds in a supramolecular reaction.14 
The combination of hydrogen bonding (HB) and halogen 
bonding (XB) is gaining a lot of importance in crystal 
engineering,15 and in order to investigate the structure-35 
directing balance between HBs and XBs we decided to 
employ a set of bi-functional donor molecules equipped with 
one HB donor and one XB donor attached to the same 
molecular backbone; 4-iodotetrafluorobenzoic acid (COOH-
I), 4-bromotetrafluorobenzoic acid (COOH-Br), 4-40 
iodotetrafluorophenol (OH-I), 4-bromotetrafluorophenol (OH-
Br), 4-iodotetrafluoroaldoxime (Ox-I) and 4-
bromotetrafluoroaldoxime (Ox-Br) (Scheme 1).  These probe 
molecules were subsequently co-crystallized with two 
isomeric symmetric acceptors 3,3’-and  4,4’-azobipyridine 45 
(3,3’-azpy and 4,4’-azpy, respectively)  (Scheme 1).  
 
 
Scheme 1. Bi‐functional donors and isomeric symmetric acceptors  
In this study, we investigate the following; 50 
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1) Competition between HB and XB donors for the 
pyridine nitrogen atoms which are capable of 
forming both hydrogen bonds and halogen bonds, 
(Scheme 2). 
 5 
Scheme 2. Postulated outcomes in our study 
2) Possible influence of geometric differences of the 
donors and acceptors on the competition and overall 
structural outcome. 
3) Participation of auxiliary potential acceptors like 10 
carbonyl oxygen atoms, hydroxyl oxygen atoms and 
azo nitrogen atoms (Scheme 3) in weaker 
interactions with halogen atoms. 
      
 15 
Scheme 3. Potential secondary interactions between halogen and 
oxygen/azo‐nitrogen 
In Scheme 2, we have outlined the postulated structural 
outcomes of the co-crystallizations as a function of the 
relative strength and supramolecular efficiency of HB vs. XB 20 
in this series of co-crystallizations.   
It is well known that electrostatic charge is important for 
predicting or rationalizing molecular recognition events,16 but 
in this study, the two acceptor molecules have rather similar 
electrostatic potentials of interaction as indicated by the 25 
charges 174 and 172 kJ/mol for 3,3’-azpy and 4,4’-azpy 
respectively, for which the maxima and minima in the 
molecular electrostatic potential surface (0.002 e au-1) were 
determined using a positive charge in vacuum as the probe 
after optimizing their molecular geometries using DFT 30 
(B3LYP, 6-31++G**) basis set. There is therefore no real 
charge-based ‘bias’ in the two acceptors. However, there is a 
geometric difference since the binding sites differ in their 
relative orientation, i.e. in case of 3,3’-azpy, the pyridine 
nitrogen atoms are aligned anti-parallel whereas in 4,4’-azpy 35 
they are co-linear with respect to each other (Scheme 1). It is 
conceivable that this difference, may affect the primary 
molecular recognition events, which can subsequently lead to 
the formation of distinctly different supramolecular 
assemblies. 40 
 
Experimental set up 
A library of six bifunctional halogen-hydrogen bond donors 
and two symmetric acceptors (Scheme 1) was employed. 3,3’-
azobipyridine and 4,4’-azobipyridine,17 4-45 
iodotetrafluorobenzoic acid and 4-bromotetrafluorobenzoic 
acid18 were synthesised as reported. 4-iodotetrafluorophenol, 
4-iodotetrafluoroaldoxime, 4-bromotetrafluoroaldoxime were 
synthesised in one-step from their corresponding 4-
halotetrafluoroaldehydes via greener solvent-assisted grinding 50 
method developed in our group. Synthesis of all the HB-XB 
donors is included in the supporting information. 4-
bromotetrafluorophenol was purchased from Sigma Aldrich. 
The donors and acceptors were combined in stoichiometric 
amounts giving a total of 12 co-crystal combinations, the 55 
synthesis of which is reported in Table 1. Single crystals were 
obtained upon slow evaporation of the solvent, and we were 
able to obtain crystals suitable for single-crystal diffraction for 
all twelve reactions.  The structural outcomes are summarized 
below. 60 
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Table 1. Synthesis of 3,3’-and 4,4’-azobipyridine co-crystals 
Acceptors Donors Co-crystal abbreviation Mole ratio Solvent/ method Melting points ºC 
 
 
 
 
 
 
 
3,3’-azobipyridine 
4-iodotetrafluorobenzoicacid 3,3’-azpy:COOH-I 1:1 Ethanol/ slow 
evaporation 
182-185 
4-bromotetrafluorobenzoicacid 3,3’-azpy:COOH-Br 1:1 Ethanol/ slow 
evaporation 
155-157 
4-iodotetrafluorophenol 3,3’-azpy:OH-I 1:1 Ethanol/ slow 
evaporation 
125-127 
4-bromotetrafluorophenol 3,3’-azpy:OH-Br 1:1 Ethanol/ slow 
evaporation 
170-173 
4-iodotetrafluoroaldoxime 3,3’-azpy:Ox-I 1:1 Ethanol/ slow 
evaporation 
145-148 
4-bromotetrafluoroaldoxime 3,3’-azpy:Ox-Br 1:1 Ethanol/ slow 
evaporation 
105-108 
 
 
 
 
 
 
    4,4’-azobipyridine 
4-iodotetrafluorobenzoicacid 4,4’-azpy:COOH-I 1:1 Ethanol/ slow 
evaporation 
220-222 
4-bromotetrafluorobenzoicacid 4,4’-azpy:COOH-Br 1:1 Ethanol/ slow 
evaporation 
190-191 
4-iodotetrafluorophenol 4,4’-azpy:OH-I 1:1 Ethanol/ slow 
evaporation 
163-165 
4-bromotetrafluorophenol 4,4’-azpy:OH-Br 1:1 Ethanol/ slow 
evaporation 
133-136 
4-iodotetrafluoroaldoxime 4,4’-azpy:Ox-I 1:1 Ethanol/ slow 
evaporation 
115-116 
4-bromotetrafluoroaldoxime 4,4’-azpy:Ox-Br 1:1 Ethanol/ slow 
evaporation 
125-126 
 
X-Ray Crystallography 
Datasets were collected on a Bruker SMART APEX II system 
with Mo radiation (3,3’-azpy:COOH-I, 3,3’-azpy:OH-I ) 5 
3,3’-azpy:OH-Br, 3,3’-azpy:Ox-I, 3,3’-azpy:Ox-Br, 4,4’-
azpy:COOH-I, 4,4;azpy:OH-Br, 4,4’azpy:Ox-I or a Bruker 
Kappa APEX II system with Cu radiation (3,3’-azpy:COOH-
Br, 4,4’-azpy:COOH-Br, 4,4’-azpy:OH-I, 4,4’-azpy:Ox-
Br) at 120 K using APEX2 software.19 An Oxford Cryostream 10 
700 low-temperature device was used to control temperature. 
MoK radiation was used. Initial cell constants were found by 
small widely separated “matrix” runs.  Data collection 
strategies were determined using COSMO.20 Scan speeds and 
scan widths were chosen based on scattering power and peak 15 
rocking curves. 
Unit-cell constants and orientation matrices were improved by 
least-squares refinement of reflections threshold from the 
entire dataset. Integrations were performed with SAINT,21 
using these improved unit cells as a starting point. Precise unit 20 
cell constants were calculated in SAINT from the final 
merged datasets. Lorenz and polarization corrections were 
applied. Absorption corrections was applied using SADABS22 
Datasets were reduced with SHELXTL.23 The structures were 
solved by direct methods without incident. Coordinates for all 25 
oxime and phenol hydrogen atoms were allowed to refine. All 
other hydrogen atoms were assigned to idealized positions and 
were allowed to ride. Isotropic thermal parameters for the 
hydrogen atoms were constrained to be 1.5x (methyl) / 1.2x 
(all other) that of the connected atom. 30 
3,3’-azpy:COOH-I Two orientations for the haloacid were 
located, in roughly head-to-tail positions. Geometry for the 
two components was restrained to similarity by using the 
SHELXL “SAME” command. Thermal parameters of closely 
located atoms were pairwise constrained using the SHELXL 35 
“EADP” command. Coordinates of the ammonium proton 
H11 were allowed to refine. 
3,3’-azpy:COOH-Br Coordinates for the carboxylic acid 
proton H21 were allowed to refine. 
3,3’-azpy:OH-I Coordinates for the carboxylic acid proton 40 
H21 were allowed to refine. 
3,3’-azpy:OH-Br Coordinates for the phenol protons H31 and 
H41 were allowed to refine.. 
3,3’-azpy:Ox-I  Coordinates for the oxime proton H27 
were allowed to refine. 45 
3,3’-azpy:Ox-Br Coordinates for the oxime proton H17 were 
allowed to refine 
4,4’-azpy:COOH-I The sample was a racemic twin, and 
populations of the two components was parameterized using 
the SHELXL “TWIN” and “BASF” commands. Two 50 
orientations for the haloacid were located, in roughly head-to-
tail positions. Geometry for the two components was 
restrained to similarity by using the SHELXL “SAME” 
command. Thermal parameters of closely located atoms were 
pairwise constrained using the SHELXL “EADP” command. 55 
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Thermal parameters for the nearly inversion-related pyridines 
N11-C16 and N21-C26 were also constrained using the 
“EADP” command, and these thermal parameters were 
restrained to approximately the same values using the 
SHELXL “SIMU” command. The ammonium proton H11 5 
was placed in an idealized geometry and allowed to ride on its 
parent nitrogen atom. 
4,4’-azpy:COOH-Br The asymmetric unit contains two acid / 
base pairs, each of which was assigned to a SHELXL RESI 
due for consistent labelling purposes. Two orientations for 10 
each halo acid were located, in roughly head-to-tail positions. 
Similarly, two closely related orientations for the amine were 
found. Geometry for all four acid components was restrained 
to similarity by using the SHELXL “SAME” command. 
Geometry for all four base components was also restrained to 15 
similarity by using the SHELXL “SAME” command. Thermal 
parameters of closely located atoms were pairwise constrained 
using the SHELXL “EADP” command. 
4,4’-azpy:OH-I The phenol proton H31 was placed in an 
idealized geometry and allowed to ride on its parent oxygen 20 
atom. 
4,4’-azpy:OH-Br Coordinates for the phenol proton H11 
were allowed to refine. 
4,4’-azpy:Ox-I  Coordinates for the oxime proton H37 were 
allowed to refine. 25 
4,4’-azpy:Ox-Br  Coordinates for the oxime proton H27 were 
allowed to refine. 
 
 Selected hydrogen and halogen-bond geometries are shown 
in Table 2 and 3 respectively. The crystallographic parameters 30 
of 3,3’- and 4,4’-azobipyridine co-crystals are listed in Table 
4a and 4b, respectively. 
 
 
Table 2 Hydrogen-bond geometries in co-crystals of 3,3’- and 4,4’-azobipyridinea 35 
Structure D–H…A/Å D–H/Å HA/Å DA/Å D–HN/° 
3,3’-azpy:COOH-I N(11)-H(11)O(21A)_#1 1.22(2) 1.32(2) 2.536(2) 174(2) 
 
3,3’-azpy:COOH-Br O(21)-H(21)N(11)_#1 1.14(3) 1.41(3) 2.549(2) 177(3) 
3,3’-azpy:OH-I O(21)-H(21)N(11)_#1 0.90(2) 1.75(2) 2.6162(15) 159(2) 
3,3’-azpy:OH-Br O(31)-H(31)N(11) 
O(41)-H(41)N(21) 
0.88(2) 
0.88(2) 
1.77(2) 
1.73(2) 
2.6224(16) 
2.5963(15) 
163.2(18) 
166.8(18) 
    
3,3’-azpy:Ox-I O(27)-H(27)N(27)_#1_#2 0.72(2) 2.18(2) 2.8460(17) 153(2) 
3,3’-azpy:Ox-Br O(17)-H(17)N(21)_#1 0.76(4) 1.95(4) 2.708(3) 178(4) 
4,4’-azpy:COOH-I N(11)-H(11)O(31B)_#1 0.88 
0.88 
1.75 
1.73 
2.605(9) 
2.598(6) 
164.3 
167.5 
4,4’-azpy:COOH-Br O31A1-H31A1N11A1 
O31B1-H31B1N21B1_#1 
O31A2-H31A2N11A2 
O31B2-H31B2N21B2_#2 
0.84 
0.84 
0.84 
0.84 
1.76 
1.84 
1.75 
1.83 
2.566(10) 
2.67(3) 
2.587(9) 
2.67(4) 
158.8 
167.6 
170.0 
175.3 
 
4,4’-azpy:OH-I O(31)-H(31)N(11) 0.84 1.84 2.614(4) 152.3 
 
4,4’-azpy:OH-Br O(31)-H(31)N(11) 0.83(2)  1.86(2) 2.6342(16) 155(2) 
4,4’-azpy:Ox-I O(37)-H(37)N(11) 0.82(2) 1.90(2) 2.7052(19) 169(2) 
 
4,4’-azpy:Ox-Br O(27)-H(27)N(11)_#1 0.94(6) 1.79(6) 2.704(6) 162(6) 
 
a
 Symmetry codes: 3,3’-azpy:COOH-I  #1 -x-1,-y,-z+2. 3,3’-azpy:COOH-Br  #1 -x+2,-y+1,-z.   3,3’-azpy:OH-I  #1 -x+1,-y+1,-z+1. 3,3’-azpy:Ox-I  #1 -
x,-y,-z+2  #2 -x+3,-y+1,-z.  3,3’-azpy:Ox-Br #1 -x,-y,-z-1. 4,4’-azpy:COOH-I  #1 x+2,y-2,z+1. 4,4’-azpy:COOH-Br #1 x-1,y+1,z+1    #2 x+2,y+1,z+1.  
4,4’-azpy:Ox-Br #1 -x+2,-y+3,-z+1       
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Table 3 Halogen-bond geometries in co-crystals of 3,3’-and 4,4’ azobipyridinea 
Structure C-XA XA/Å C-XA/° 
3,3’-azpy:COOH-I C-(24A)-I(1)O(22A)_#2 2.8694(13) 170.66(6) 
3,3’-azpy:COOH-Br C-(24)-Br(1)O(22)_#2 2.8792(17) 
 
172.23(7) 
3,3’-azpy:OH-I C(24)-I(1)O(21)_#2  
 
3.0913(10) 156.81(4) 
3,3’-azpy:OH-Br C(34)-Br(1)O(31)_#1 
C(44)-Br(2) O(41)_#2 
 
3.1138(11) 
3.0750(10) 
156.32(5) 
158.68(5) 
3,3’-azpy:Ox-I C(24)-I(1)N(11) 2.8279(12) 174.75(4) 
3,3’-azpy:Ox-Br C(14)-Br(1)O(17)_#1 3.0557(19) 158.49(9) 
4,4’-azpy:COOH-I C(34A)-I(1A) N(21)_#1 2.796(5) 173.4(3) 
4,4’-azpy:COOH-Br C(34A1)-Br(1A1)N(21A1)_#1 2.802(7) 176.9(4) 
4,4’-azpy:OH-I C(34)-I(1)N(21)_#1 2.960(3) 165.98(11) 
4,4’-azpy:OH-Br C(34)-Br(1)N(21)_#1 2.9717(12) 165.95(5) 
4,4’-azpy:Ox-I C(34)-I(1)N(21)_#1 2.8200(15) 178.38(5) 
 
4,4’-azpy:Ox-Br C(24)-Br(1)N(14)_#1 3.395(4) 171.94(17) 
a Symmetry codes  3,3’-azpy:COOH-I  #2 x+1,-y+1/2,z-1/2. 3,3’-azpy:COOH-Br  #2 x-1,-y+1/2,z+1/2.  3,3’-azpy:OH-I #2 -x+1/2,y-1/2,-z+3/2.  3,3’-
azpy:OH-Br  #1 -x+1,y-1/2,-z+1/2    #2 -x,y+1/2,-z+3/2. 3,3’-azpy:Ox-Br #1 x,y+1,z+1. 4,4’-azpy:COOH-I  #1 x-2,y+2,z-1. 4,4’-azpy:COOH-Br  #1 x-
1,y+1,z+1. 4,4’-azpy:OH-I  #1 x-2,y+1,z+1. 4,4’-azpy:OH-Br #1 x+2,y-1,z-1. 4,4’-azpy:Ox-I  #1 x-1/2,-y-1/2,z+1/2. 4,4’-azpy:Ox-Br #1 x-1/2,-y+3/2,z-
1/2.       5 
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Table 4a Crystallographic parameters of 3,3’-azobipyridine co-crystals 
 3,3’-azpy:COOH-I 3,3’-azpy:COOH-Br 3,3’-azpy:OH-I 3,3’-azpy:OH-Br 3,3’-azpy:Ox-I 3,3’-azpy:Ox-Br 
Formula moiety (C10H8N4) 
(C7HF4IO2)2 
(C10H8N4) 
(C7HBrF4O2)2 
(C10H8N4) 
(C6HF4IO)2 
(C10H8N4) 
(C6HBrF4O)2 
(C10H8N4) 
(C7H2F4INO)2 
(C10H8N4) 
(C7H2BrF4NO)2 
Empirical formula C24H10F8I2N4O4 C24H10Br2F8N4O4 C22H10F8I2N4O2 C22H10Br2F8N4O2 C24H12F8I2N6O2 C24H12Br2F8N6O2 
Molecular weight 824.16 730.18 768.14 674.16 822.20 728.22 
Color,  Habit orange rod orange plate orange plate orange prism orange prism orange plate 
Crystal system Monoclinic Monoclinic Monoclinic Monoclinic Triclinic Triclinic 
Space group,  Z P21/c, 2 P21/c, 2 C2/c, 4 P21/c, 4 P-1, 1 P-1, 1 
a, Å 4.9020(3) 4.8724(3) 19.0228(11) 18.2149(8) 5.6341(4) 8.3500(8) 
b, Å 21.4561(12) 22.0007(13) 16.8636(10) 16.4379(7) 10.4834(7) 8.3646(8) 
c, Å 12.1298(7) 11.6936(7) 7.2425(4) 7.4736(4) 11.5197(8) 9.8996(10) 
, ° 90.00 90.00 90.00 90.00 75.365(2) 105.765(3) 
, ° 100.151(2) 101.336(3) 93.198(2) 99.631(2) 77.562(2) 103.151(3) 
, ° 90.00 90.00 90.00 90.00 80.975(2) 99.733(3) 
Volume,Å3 1255.82(13) 1229.06(13) 2319.7(2) 2206.17(18) 639.09(8) 628.00(11) 
X-ray wavelength 0.71073 1.54178 0.71073 0.71073 0.71073 0.71073 
, mm-1 2.606 5.151 2.806 3.774 2.556 3.325 
Absorption corr multi-scan multi-scan multi-scan multi-scan multi-scan multi-scan 
Trans min / max 0.4893 / 0.8186 0.5657 / 0.7531 0.4671 / 0.8497 0.3602 / 0.4906 0.4951  0.7161 0.4159 / 0.8255 
Reflections       
   collected 13823 7259 18196 62309 15760 10635 
   independent 4126 2158 3957 7628 4637 3773 
   observed 3713 2046 3666 6276 4497 3174 
Threshold expression >2(I) >2(I) >2(I) >2(I) >2(I) >2(I) 
R1 (observed) 0.0207 0.0261 0.0176 0.0265 0.0186 0.0480 
wR2 (all) 0.0508 0.0688 0.0463 0.0699 0.0444 0.1288 
S 1.064 1.084 1.021 0.998 1.085 1.052 
. 
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Table 4b Crystallographic parameters of 4,4’-azobipyridine co-crystals 
 4,4’-azpy:COOH-I 4,4’-azpy:COOH-Br 4,4’-azpy:OH-I 4,4’-azpy:OH-Br 4,4’-azpy:Ox-I 4,4’-azpy:Ox-Br 
Formula moiety (C10H8N4) 
(C7HF4IO2) 
(C10H8N4) 
(C7HBrF4O2) 
(C10H8N4) 
(C6HF4IO) 
(C10H8N4) 
(C6HBrF4O) 
(C10H8N4) 
(C7H2F4INO) 
(C10H8N4) 
(C7H2BrF4NO)2 
Empirical formula C17H9F4IN4O2 C17H9BrF4N4O2 C16H9F4IN4O C16H9BrF4N4O C17H10F4IN5O C24H12Br2F8N6O2 
Molecular weight 504.18 457.19 476.17 429.18 503.20 728.22 
Color,  Habit bronze plate orange prism orange plate colourless plate orange plate orange needle 
Crystal system Triclinic Triclinic Triclinic Triclinic Monoclinic Monoclinic 
Space group,  Z P1, 1 P-1, 4 P-1, 2 P-1, 2 C2/c, 8 P21/n, 2 
a, Å 6.2112(8) 10.1607(5) 6.1515(5) 6.3706(3) 17.6282(7) 10.2846(10) 
b, Å 8.1879(11) 13.4553(6) 9.8197(7) 9.5670(5) 6.3167(3) 4.6215(5) 
c, Å 8.9824(12) 14.4474(8) 13.7443(10) 13.3289(7) 31.7318(14) 27.841(2) 
, ° 84.843(3) 112.158(3) 81.558(3) 79.453(2) 90.00 90.00 
, ° 70.837(3) 90.592(3) 85.932(3) 83.090(2) 96.518(2) 98.246(6) 
, ° 77.402(3) 111.504(3) 78.342(3) 79.4760(10) 90.00 90.00 
Volume,Å3 421.03(10) 1676.48(14) 803.57(10) 782.03(7) 3510.6(3) 1309.6(2) 
X-ray wavelength 0.71073 1.54178 1.54178 0.71073 0.71073 1.54178 
, mm-1 1.967 3.967 16.211 2.687 1.884 4.795 
Absorption corr multi-scan multi-scan multi-scan multi-scan multi-scan multi-scan 
Trans min / max 0.5544 / 0.9255 0.5354 / 0.7420 0.1813 / 0.5633 0.5804 / 0.7464 0.6401 / 0.9284 0.5662 / 0.7531 
Reflections       
   collected 8655 18301 11713 17166 27187 7830 
   independent 4606 5840 2764 5315 6206 2257 
   observed 4415 5035 2604 4829 5308 1721 
Threshold expression >2(I) >2(I) >2(I) >2(I) >2(I) >2(I) 
R1 (observed) 0.0433 0.0851 0.0275 0.0269 0.0239 0.0595 
wR2 (all) 0.1149 0.2211 0.0756 0.0720 0.0575 0.1586 
S 1.062 1.038 1.082 1.037 1.040 1.099 
      
   
Results 
Co-crystals of 3,3’-azobipyridine 5 
3,3’-Azobipyridine:4-iodotetrafluorobenzoic acid 
The crystal structure determination of 3,3’-azpy:COOH-I  
 
 
shows that the result is a neutral molecular solid with two acid 10 
molecules for every one bipy.  The co-crystal is formed via 
two symmetry related O-HN hydrogen bonds between one 
carboxylic acid and a nitrogen atom, Table 2. These 
interactions lead to trimeric supermolecules which are 
subsequently connected into 2-D corrugated sheets via C-15 
IO(C=O), (Fig 1).   
 
Fig.1 2‐D network formed via strong O‐HN(py) and weaker C‐IO(C=O) interactions in 3,3’‐azpy:COOH‐I co‐crystal.  The apparent ‘covalent’ bond 
between COOH and py is due to a disorder over two positions of the haloacid.20 
3,3’-Azobipyridine:4-bromotetrafluorobenzoic acid 
 This journal is © The Royal Society of Chemistry [year] Journal Name, [year], [vol], 00–00  |  7 
In 3,3’-azpy:COOH-Br co-crystal, the primary driving 
force is the acid-pyridine O-HN hydrogen bonds, with 
two acid molecules for every single bipyridine. The neutral 
trimers thus formed extend further into 2-D sheets via C-
BrO(C=O) interactions (Fig 2).                                                                 5 
 
Fig. 2 3,3’‐azpy:COOH‐Br co‐crystal showing primary O‐HN(py) and secondary C‐BrO(C=O) interactions
3,3’-Azobipyridine:4-iodotetrafluorophenol 10 
4-Iodotetrafluorophenol has two potential single point donors, 
i.e. I and OH that could potentially bind to the nitrogen atoms. 
In 3,3’-azpy:OH-I however, hydroxyl proton interacts with 
the nitrogen atoms via symmetry related O-HN hydrogen 
bonds leading to a trimeric supermolecule. These trimers are 15 
then further connected along 2-D sheets via weaker C-
IO(C=O) interactions (Fig 3) 
 
Fig.3 3,3’‐azpy:OH‐I crystal structure showing primary O‐HN(py) and secondary C‐IO(C=O) interactions forming an eight component repeat unit 
 20 
3,3’-Azobipyridine:4-Bromotetrafluorophenol 
In 3,3’-azpy:OH-Br co-crystal, intermolecular O-HN 
hydrogen bonds direct the formation of primary trimeric 
building blocks. The interaction of bromine atom with 
hydroxyl oxygen lone pairs via C-BrO bond connects these 25 
building blocks in two dimensions (Fig 4). 
 
Fig.4 3,3’‐azpy:OH‐Br crystal structure showing intermolecular O‐HN(py) and C‐BrO interactions forming the multi‐component supermolecule 
 
3,3’-Azobipyridine:4-iodotetrafluoroaldoxime 30 
In the co-crystal of 3,3’-azpy-Ox-I, Iodine forms C-IN 
halogen bonds with the two pyridine nitrogen atoms, while the 
oxime engages itself in a dimer formation with another donor 
molecule (Fig 5). This results in 1-D non-planar corrugated 
chain like assembly with the donor and acceptor molecules 35 
aligned almost perpendicular to each other. Among all the co-
crystals of 3,3’-azobipyridine with bifunctional donor 
molecules, this is the only example in which halogen bonds 
are formed as the primary mode of interaction, in contrast to 
hydrogen bonds. 40 
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Fig.5 3,3’‐azpy:Ox‐I co‐crystal with oxime‐oxime dimer and C‐IN(py) halogen bonds forming 1‐D non‐planar corrugated chain 
  5 
3,3’-Azobipyridine:4-bromotetrafluoroaldoxime 
3,3’-azpy:Ox-Br co-crystal shows an aldoxime proton 
interacting with pyridine via symmetry related O-HN 
hydrogen bonds, while the aldoxime oxygen interacts with 
bromine via C-BrO contacts forming the supermolecule (Fig 10 
6). 
 
 
           Fig.6 3,3’-azpy:Ox-Br crystal structure showing O-HN(py) primary hydrogen bonds and secondary C-BrO interactions
15 
 
Co-crystals of 4,4’-azobipyridine 
 
 
4,4’-Azobipyridine:4-iodotetrafluorobenzoic acid 20 
In 4,4’-azpy:COOH-I co-crystal, intermolecular O-HN  
hydrogen bonds as well as C-IN  halogen bond interactions 
form neutral molecular solids with  infinite 1-D chain like 
architecture (Fig 7). 
25 
 
Fig.7 1‐D infinite chain in 4,4’‐azpy:COOH‐I co‐crystal formed via O‐HN(py) and C‐IN(py) hydrogen and halogen bond, respectively.  For specific 
information about the crystallography, see the experimental section
 
4,4’-Azobipyridine:4-bromotetrafluorobenzoic acid 30 
4,4’-azpy:COOH-Br co-crystal exhibits infinite 1-D chains 
formed via intermolecular neutral O-HN hydrogen bonds as 
well as C-BrN halogen bonds on the other (Fig 8). 
Journal Name 
Cite this: DOI: 10.1039/c0xx00000x 
www.rsc.org/xxxxxx 
Dynamic Article Links ►
PAPER
 
This journal is © The Royal Society of Chemistry [year] [journal], [year], [vol], 00–00  |  9 
 
Fig.8 4,4’‐azpy:COOH‐Br co‐crystal showing primary O‐HN(py) hydrogen bonds and C‐BrN(py) halogen bond interactions 
 
4,4’-Azobipyridine:4-iodotetrafluorophenol 
In 4,4’-azpy:OH-I co-crystal, both hydroxyl proton and 5 
iodine bind to the pyridine N on either sides, via O-HN and 
C-IN(py) bonds forming an infinite 1-D chain (Fig 9). 
 
Fig.9 4,4’‐azpy:OH‐I crystal structure indicating 1‐D chains formed via both O‐HN(py) and C‐IN(py) primary interactions 10 
 
4,4’-Azobipyridine:4-bromotetrafluorophenol 
4,4’-azpy:OH-Br co-crystal displays 1-D infinite chain formed 
via intermolecular O-HN hydrogen bonds as well as C-BrN 
halogen bonds (Fig 10). 15 
       
    Fig.10 4,4’‐azpy:OH‐Br co‐crystal structure showing 1‐D chain formed via both hydrogen (O‐HN(py)) and halogen (C‐BrN(py)) bonds  
4,4’-Azobipyridine:4-iodotetrafluoroaldoxime 
In 4,4’-azpy:Ox-I co-crystal, 1-D infinite zig-zag chains are 
formed via both hydrogen (O-HN) as well as halogen bonds 20 
(C-IN) bonds (Fig 11). 
 
 
Fig.11 4,4’‐azpy:Ox‐I crystal structure with primary C‐IN(py) and O‐HN(py) interactions forming 1‐D tape
25 
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4,4’-Azobipyridine:4-bromotetrafluoroaldoxime 
Unlike in the previous structures, in the 4,4’-azpy:Ox-Br co-
crystal, the aldoxime proton interacts via oximepyridine 
hydrogen bonds on both sides, while bromine on the other end 
displays interactions with the azo nitrogen (C-BrN(azo), 3.397Å) 5 
(Fig 12a). The bond distance is longer than the normal C-
XNaromatic (2.97 Å), but slightly shorter than the sum of their 
van der Waal radii (3.40 Å). The halogen bonding ability of azo-
nitrogen is a rare occurrence and does not have many precedents 
in literature.  The BrN(azo) interaction aligns the azobipyridine 10 
almost perpendicular to the plane, thus forming 3-D architecture 
as seen in Fig 12b. 
        
             Fig.12a 4,4’-azpy:Ox-Br crystal structure with primary O-HN(py) hydrogen bonds and secondary C-BrN(azo) interactions 
 15 
Fig. 12b 3D‐architecture in 4,4’azpy:OxBr co‐crystal
Discussion 20 
Twelve co-crystallizations were set up using two isomeric 
pyridine-based acceptors (3,3’-and 4,4’-azobipyridine) and six bi-
functional donors comprising both a HB donor (acid, phenol and 
oxime) as well as an XB donor (iodine and bromine) on the same 
backbone. Single-crystal structural data were acquired for solids 25 
obtained from all 12 reactions. The primary interactions driving 
the crystal assembly were the O-HN(py) hydrogen bonds or C-
XN(py) halogen bonds followed by secondary interactions which 
were used to connect the primary motifs. In all co-crystals, there 
were several potential acceptors e.g. N(py), N(azo), O(-O=C) and 30 
O(-OH), and donors e.g. acid, phenol, oxime, iodine and bromine. 
Considering the complexity of such a system,  although it was 
reasonable to expect some degree of structural ‘chaos’ in the 
supramolecular outcome, we observe remarkable consistency in 
the binding pattern within the two classes of acceptors. Table 5 35 
and Scheme 4 summarize the structural landscape in these twelve 
crystal structures. 
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Table 5 Summary of the structural outcome in 3,3’-and 4,4’-
azobipyridine co-crystals of dicarboxylic acids. 
 COOH-I 
(acid-H) 
COOH-Br 
(acid-H) 
OH-I 
(phenol-H) 
OH-Br 
(phenol-H) 
Ox-Br 
(oxime-H)
Ox-I 
(oxime-H)
 
3,3’- 
azpy 
 
OH  > I 
 
A 
 
OH  > Br 
 
A 
 
OH  > I  
 
         A 
 
OH > Br 
 
A 
 
OHox > Br
 
A 
 
 
OHox < I 
 
C 
 
4,4’- 
azpy 
 
OH = I 
 
B 
 
OH = Br 
 
B 
 
OH = I  
 
B 
 
 
OH = Br 
 
B 
 
OHox > Br
 
A 
 
OHox = I 
 
B 
 A:HB > XB, B:HB = XB, C:HB < XB 
HB
N
NN
N
HB
XB
N
NN
N
XB
N
N
N
N
XB
HB
N
N
N
N
HB
HB
3,3'-azopyridine co-crystals
4,4'-azopyridine co-crystals
5/6 1/6
5/61/6  
Scheme 4 Summary of the outcome in 3,3’‐and 4,4’‐azobipyridine co‐5 
crystals. 
Cambridge Structural Database (CSD) was used to compare the 
intermolecular bond distances for both hydrogen (O-HN) as 
well as halogen bonds (C-XN). The search in CSD was limited 
to aromatics alone. The average intermolecular hydrogen bond 10 
distances reported for acid-pyridine, phenol-pyridine and 
aldoxime-pyridine are 1.749Å, 1.935Å and 1.984 Å respectively; 
while for our crystal structures the corresponding values are 1.66 
Å, 1.79 Å and 1.88 Å. There is a good agreement in the trend 
observed for the O-HN bond distances in the reported as well as 15 
observed values which decreases in the following order, oxime-
pyridine > phenol-pyridine  > acid-pyridine.  
Similar search on aromatic halogen-pyridine halogen bond 
distance gives an average C-IN and C-BrN value of 2.883Å 
and 3.039Å respectively. Shorter bond distance for IN 20 
interaction signifies that iodine is a better donor than bromine. 
Based on our crystal structures, the average C-IN and C-BrN 
bond distance is 2.850 Å and 2.895Å respectively, which again is 
in good agreement with the results from the database and the 
electrostatic argument. Moreover, iodine forms C-IN(py) primary 25 
halogen bonds with the most basic pyridine nitrogen in 4/6 cases, 
whereas bromine forms C-BrN(py) halogen bond in only 2/6 
instances. Bromine interacts more frequently with less basic 
secondary acceptors, i.e. ‘O’ and ‘Nazo’ 4/6 times, whereas iodine 
does so only 2/6 times.  30 
 
Five out of six 3,3’-azobipyridine co-crystals (COOH-I/COOH-
Br/OH-I/OH-Br/Ox-Br) exhibit OHN(py) interactions involving 
the best acceptor leading to supramolecular trimers.  The trimers 
are then linked into 2-D corrugated sheets via weaker interactions 35 
between I/Br with a secondary acceptor such as an oxygen atom. 
Thus, in this group of structures, hydrogen bonds dominate over 
halogen bonds, i.e. HB > XB (5/6) (Scheme 4). An outlier in this 
series is 3,3’-azpy:Ox-I, where the XB donor interacts 
preferentially with the N(py) acceptor.  As a result, the ‘free’ 40 
oxime moiety forms a dimer with an oxime from a neighbouring 
molecule leading to infinite 1-D chain-like structure.24  In this 
crystal structure, since the hydrogen-bonding group (oxime) is 
involved in a homomeric dimer, the halogen bond ‘wins’, i.e. HB 
< XB (1/6) (Scheme 4).  45 
In contrast, in five out of six 4,4’-azobipyridine co-crystals 
(COOH-I/COOH-Br/OH-I/OH-Br/Ox-I) 1-D chains are obtained 
via both O-HN(py) hydrogen and C-XN(py) (X=I/Br) halogen 
bonds with the N(py) acceptor site.  In this group, both donors are 
of equal importance in the primary assembly process, i.e. HB  50 
XB (5/6) (Scheme 4). There is no distinction between bromine 
and iodine as a halogen-bond donor in any of the co-crystals.  An 
outlier in the series is 4,4’-azpy:Ox-Br where the oximepyridine 
hydrogen bonds direct the crystal structure i.e. HB > XB (1/6) 
(Scheme 4). It is interesting to note the appearance of a rare C-55 
BrN(azo) halogen bond in this structure. The azo nitrogen is a 
very weak acceptor compared to oxygen and hence the inclination 
of bromine to bind to it is surprising. This interaction aligns the 
azobipyridine almost perpendicular to the plane thus leading to a 
three dimensional molecular assembly. This observation does 60 
introduce the possibility for a new prospective acceptor site (azo 
nitrogen) that could be further explored in designing new 
strategies for directed assembly of complex supramolecular 
architectures.   
There is a clear distinction between the primary molecular 65 
recognition events in the two classes of azobipyridine co-crystals 
with same co-formers. In one case, hydrogen bonding is the 
preferred interaction whereas in the other case HB and XB seem 
to be of equal importance. This difference cannot be explained on 
the basis of any charge argument on the acceptor molecules, since 70 
the charges on the nitrogen atoms in the two azobipyridines differ 
by only 2kJ/mol. In order to seek a plausible explanation for the 
difference in binding behavior we examined the electrostatic 
potentials of donor molecules as well as packing coefficients and 
melting point trends in the two classes of co-crystals.  75 
 
Electrostatic surface potential calculations 
Geometry optimization and surface potential calculations were 
performed on six bi-functional donor molecules using Spartan, 
2010 (Wave function, Inc. Irvine, CA). Calculations were done 80 
using both Semi-empirical (PM3) as well as Density Functional 
Theory (DFT), (B3LYP, 6-31++G** basis set) models. Table 6 
summarizes the outcome of theoretical calculations. 
Table 6 Electrostatic surface potentials expressed as charges in kJ/mol 
 COOH-I COOH-Br OH-I OH-Br Ox-I Ox-Br 
 H I H Br H I H Br H I H Br 
PM3 144 222 144 160 156 202 163 152 134 204 135 147
DFT 296 166 305 142 305 155 314 121 283 153 276 129
 85 
Based on both PM3 as well as DFT calculations, the following 
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trend in surface potentials is observed among the hydrogen bond 
donors, phenol > acid > aldoxime, while the among the halogen 
atoms iodine shows a greater positive sigma hole potential 
compared to bromine. However; when comparing the relative 
sigma potentials of hydrogen atom and halogen atom on the same 5 
molecule, PM3 calculations show a higher positive potential for 
halogen atom whereas DFT shows a higher potential for 
hydrogen atom. The electrostatic potential values do not show 
any apparent differences or trends between hydrogen and halogen 
bond atom that could explain the two different molecular 10 
recognition events witnessed in 3,3’- and 4,4’- azpy co-crystals, 
and hence could not be used to corroborate the experimental 
trend. 
 
Packing Coefficients and Melting points 15 
Packing coefficients were calculated for all 12 co-crystals using 
the Olex2 v1.2 software. Table 7a and 7b summarizes the packing 
coefficient and melting point values of all 3,3’-azpy and 4,4’-
azpy co-crystals 
Table 7a 3,3’-azpy cocrystals 20 
 COOH-I COOH-Br OH-I OH-Br Ox-I Ox-Br 
Packing 
coefficient 
(%) 
 
74 
 
69 
 
68 
 
71 
 
69 
 
69 
Melting 
points 
 (ºC) 
182-185 155-157 125-127 170-173 145-148 105-108
   
Table 7b 4,4’-azpy co-crystals 
 COOH-I COOH-Br OH-I OH-Br Ox-I Ox-Br 
Packing 
coefficient 
(%) 
 
74 
 
76 
 
67 
 
69 
 
66 
 
67 
Melting 
points 
 (ºC) 
220-222 190-191 163-165 133-136 115-116 125-126
 
The packing coefficients for the two classes of co-crystals range 
from 66-74% and they show very similar values with the same 25 
donor molecule. Since no obvious differences are observed in the 
packing coefficient values in 3,3’- and 4,4’-azpy classes of co-
crystals it could not be used to validate the observed differences 
in supramolecular architectures. Melting points of co-crystals 
show a wide range and also fail to show any convincing trend to 30 
be able to explain the differences in the molecular assemblies 
formed. Also no clear correlation is observed between the 
packing coefficients and melting points of a given co-crystal.  
 
Since theoretical calculations, packing coefficients and melting 35 
points could not be used to explain the differences in binding 
events, this ‘synthon crossover’,25 could be rationalized based on 
the difference in binding site orientation in the two azobipyridine 
molecules. 
The nitrogen atoms on 3,3’-azobipyridine have an anti-parallel 40 
orientation with respect to each other (Scheme 1). This geometry 
does not favour the ready formation of 1-D chains as the lack of 
ideal complementary means that adjacent molecules need to be 
forcefully brought in close proximity at angles that can enforce a 
1-D assembly formation. In doing so the overall energy of the 45 
system may increase while its stability is compromised. On the 
other hand, forming individual trimers is less challenging and 
comes natural to the system. These trimers can then be readily 
connected via secondary interactions thus leading to a stable 
structure. Under these conditions, the HB donor (which is a 50 
somewhat more competitive donor moiety) binds to the best 
acceptor site, i.e. the pyridine nitrogen, leading to a stable trimer. 
I/Br then interacts with the next best acceptor (oxygen/azo 
nitrogen) linking the trimers into a 2-D architecture.    
In 4,4’-azobipyridine however, the binding sites are co-linear 55 
which naturally favours the formation of infinite 1-D chains (a 
kinetic product) with no significant loss in energy. Under these 
conditions, the acceptor nitrogen atom binds to an XB donor as 
quickly as it binds to HB donor producing 1-D infinite chains 
constructed form alternative D-HA and XA interactions.  60 
Our results, which show a close competition between XB and HB 
donors are consistent with the work of Resnati and co-workers 
who designed a competitive experiment by combining 1,2-bis(4-
pyridyl)-ethane (BPE) as a symmetric acceptor, 1,4-
diiodotetrafluorobenzene (DITFB) as halogen-bond donor and 65 
hydroquinone (HQ) as hydrogen-bond donor in a single-pot.26 
Selective halogen-bonded co-crystal formation was observed, 
leaving the hydrogen-bond donor in a solution. The result 
suggests suitable XB donors can compete with certain HB donors 
and preferentially bind to the acceptor to give stable binary co-70 
crystals. Similarly C.M Cho et al and D.W. Bruce et al designed 
liquid crystals using the combination of both halogen as well as 
hydrogen bonds affixed on the same backbone.27 
 
We have established that the orientation of the binding site in the 75 
acceptor can influence supramolecular assembly in very specific 
ways, and several points can be made based on the crystal 
structure analysis for 3,3’-and 4,4’-azobipyridine co-crystals; 
1) In 3,3’-azpy co-crystals hydrogen bonding is the 
primary driving force (HB > XB), while in 4,4’-azpy 80 
co-crystals both hydrogen as well as halogen bonds 
equally contribute in the assembly process (HB  XB). 
2) Among the halogen atoms, iodine is a better halogen-
bond donor than bromine. 
3) There is no distinction between three types of 85 
hydrogen-bond donors (-COOH, -OH and –CN(R)OH) 
in terms of binding to the azobipyridines in the 
presence of halogens.  
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